Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kern

Showing results (191-200 of 397) with videos related to

Pageof 40
Sort By:
Trials|June 5, 2020
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trialJonathan Rilinger, Winfried V Kern, Daniel Duerschmied, et al.
BMC Infectious Diseases|August 10, 2013
Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlatesChristian Theilacker, Jürgen Held, Ludger Allering, et al.
Frontiers in Public Health|May 13, 2022
Closing Sexual Health Service Gaps With a New Service Model in Germany: Performance of an on-Site Integrated, Cross-Sectoral, Low Threshold Sexually Transmitted Infections/HIV Counseling and Treatment ServiceMatthias C Müller, Susanne Usadel, Stefan Zimmermann, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitorsSabine Schuster, Samay Kohler, Annika Buck, et al.
BMC Infectious Diseases|October 30, 2015
Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literatureSiegbert Rieg, M Fabian Küpper, Katja de With, et al.
Emerging Infectious Diseases|November 7, 2009
Dirofilaria repens infection and concomitant meningoencephalitisSven Poppert, Maike Hodapp, Andreas Krueger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2005
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignanciesStefan Reuter, Winfried V Kern, Anja Sigge, et al.
Cancer|September 16, 2006
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisionsLeonard Leibovici, Mical Paul, Michael Cullen, et al.
The Journal of Infection|September 6, 2011
Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivationJan Thoden, Siegbert Rieg, Nils Venhoff, et al.
Journal of Bacteriology|October 14, 2008
Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrBJürgen A Bohnert, Sabine Schuster, Markus A Seeger, et al.
Pageof 40

Showing results (191-200 of 397) with videos related to

Sort By:
Pageof 40
Trials|June 5, 2020
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trialJonathan Rilinger, Winfried V Kern, Daniel Duerschmied, et al.
BMC Infectious Diseases|August 10, 2013
Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlatesChristian Theilacker, Jürgen Held, Ludger Allering, et al.
Frontiers in Public Health|May 13, 2022
Closing Sexual Health Service Gaps With a New Service Model in Germany: Performance of an on-Site Integrated, Cross-Sectoral, Low Threshold Sexually Transmitted Infections/HIV Counseling and Treatment ServiceMatthias C Müller, Susanne Usadel, Stefan Zimmermann, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitorsSabine Schuster, Samay Kohler, Annika Buck, et al.
BMC Infectious Diseases|October 30, 2015
Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literatureSiegbert Rieg, M Fabian Küpper, Katja de With, et al.
Emerging Infectious Diseases|November 7, 2009
Dirofilaria repens infection and concomitant meningoencephalitisSven Poppert, Maike Hodapp, Andreas Krueger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2005
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignanciesStefan Reuter, Winfried V Kern, Anja Sigge, et al.
Cancer|September 16, 2006
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisionsLeonard Leibovici, Mical Paul, Michael Cullen, et al.
The Journal of Infection|September 6, 2011
Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivationJan Thoden, Siegbert Rieg, Nils Venhoff, et al.
Journal of Bacteriology|October 14, 2008
Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrBJürgen A Bohnert, Sabine Schuster, Markus A Seeger, et al.
Pageof 40